Jingkun Bai

机构：Weifang Medical University, Second Hospital of Shandong University · ORCID：0000-0001-9749-2213

发表论文 58 篇 · 总被引 1070 次 · h-index 21

代表论文

• Polyrotaxanated covalent organic frameworks based on β-cyclodextrin towards high-efficiency synergistic inactivation of bacterial pathogens (2024 · Chemical Engineering Journal · 被引 28)
• Morphologically transformable peptide nanocarriers coloaded with doxorubicin and curcumin inhibit the growth and metastasis of hepatocellular carcinoma (2023 · Materials Today Bio · 被引 22)
• pH‐Triggered Transformable Peptide Nanocarriers Extend Drug Retention for Breast Cancer Combination Therapy (2024 · Advanced Healthcare Materials · 被引 20)
• Advances in the variations and biomedical applications of stimuli-responsive nanodrug delivery systems (2024 · Nanotechnology · 被引 13)
• Enzyme-Induced Shape-Shifting Peptide Nanocarrier Coloaded with Paclitaxel and Dipyridamole Inhibits Platelet Function and Tumor Metastasis (2023 · ACS Applied Materials & Interfaces · 被引 13)
• An inulin-based glycovesicle for pathogen-targeted drug delivery to ameliorate salmonellosis (2024 · International Journal of Biological Macromolecules · 被引 11)